You have requested access to member-only content.

JAMA: Telemedicine proves beneficial in treating opioid use disorders

Medicare beneficiaries who took part in telemedicine visits during the pandemic were more likely to stick with medication therapies to treat their opioid use disorder (OUD) and less likely to experience a drug overdose, according to a JAMA Psychiatry study. 

This is an excerpt from member-only content. Please log in or become a member.

Not a member? Join now!

Revenue Cycle Advisor is the key to your organization's Medicare regulatory news and education. It combines all of HCPro's Medicare regulatory and reimbursement resources into one handy and easy-to-access portal. News is not just repeated from other sources. It is analyzed by our Medicare experts so professionals can comprehend any new rule updates thoroughly.

For questions and support, please call customer service: 800-650-6787.